Results 291 to 300 of about 9,492,801 (363)

Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

Journal of Clinical Oncology, 2023
PURPOSE Patients with advanced pancreatic cancer have a poor prognosis and there have been no improvements in survival since the introduction of gemcitabine in 1996.
M. Moore, D. Goldstein, J. Hamm, A. Figer, J. Hecht, S. Gallinger, H. Au, P. Murawa, D. Walde, R. Wolff, D. Campos, R. Lim, K. Ding, G. Clark, T. Voskoglou-Nomikos, Mieke Ptasynski, W. Parulekar   +16 more
semanticscholar   +1 more source

Target Trial Emulation: A Framework for Causal Inference From Observational Data.

Journal of the American Medical Association (JAMA), 2022
This Guide to Statistics and Methods describes the use of target trial emulation to design an observational study so it preserves the advantages of a randomized clinical trial, points out the limitations of the method, and provides an example of its ...
M. Hernán, Wei Wang, D. Leaf
semanticscholar   +1 more source